Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Conditioning Regimens and Outcomes after Allogeneic Hematopoietic Cell Transplant for Hyperinflammatory Inborn Errors of Immunity

Rebecca A. Marsh, Soyoung Kim, Kyle Hebert, Christopher C. Dvorak, MD, Victor Aquino, MD, K. Scott Scott Baker, MD MS, Deepak Chellapandian, MD, Blachy Davila, MD, Christine Duncan, MD, Michael J. Eckrich, MD MPH, George E. Georges, MD, Timothy S. Olson, MD PhD, Michael A Pulsipher, MD, Shalini Shenoy, MD, Elizabeth Stenger, MD, Mark Vander Lugt, MD, Lolie C. Yu, MD, Andrew Gennery, MD, Mary Eapen, MBBS, MS

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-139930

Published: 2020

Journal Articles

Long-Term Tolerance to Kidney Allografts After Induced Rejection of Donor Hematopoietic Chimerism in a Preclinical Canine Model.

David Mathes, MD, Scott Stoll Graves, PH.D., George E. Georges, MD, Christian Kuhr, MD, Jeff Chang, MD, Tiffany Butts, BA, Rainer Storb, MD

Blood (2012) 120 (21): 2991.

https://doi.org/10.1182/blood.V120.21.2991.2991

Published: 2012

Journal Articles

Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)

Richard A. Nash, MD, George J. Hutton, MD, Michael K Racke, MD, Uday R. Popat, M.D., Steven M. Devine, MD, George E. Georges, MD, Linda M. Griffith, MD, PhD, Paolo A Muraro, MD, Harry Openshaw, MD, Peter H. Sayre, MD, PhD, Olaf Stuve, MD, Douglas L Arnold, MD, Meagan Spychala, Noha Lim, PhD, Sachin Malhotra, PhD, Deborah Phippard, PhD, Annette Wundes, MD, George H Kraft, MD, James D Bowen, MD

Blood (2012) 120 (21): 962.

https://doi.org/10.1182/blood.V120.21.962.962

Published: 2012

Journal Articles

Sitagliptin Improves Engraftment and Platelet Recovery After Single Unit, Very Low Cell Dose Cord Blood Transplantation

George E. Georges, MD, Vladimir Lesnikov, MD, PhD, Robert Jordan, Anna Aragon, Ya-Ju Laura Yang, Marina Lesnikova, PhD

Blood (2011) 118 (21): 2963.

https://doi.org/10.1182/blood.V118.21.2963.2963

Published: 2011

Journal Articles

Reduced Intensity Conditioning with Allogeneic Hematopoietic Cell Transplantation for the Treatment of High-Risk Acute Lymphoblastic Leukemia.

Ron Ram, MD, Rainer F. Storb, MD, David G. Maloney, MD, Brenda M. Sandmaier, MD, Michael Maris, MD, Judith Shizuru, MD, PhD, Thomas Chauncey, MD, PhD, Amelia A. Langston, MD, George E. Georges, MD

Blood (2009) 114 (22): 1210.

https://doi.org/10.1182/blood.V114.22.1210.1210

Published: 2009

Journal Articles

Nonmyeloablative Allogeneic HCT From Unrelated Donors for Multiple Myeloma (MM).

Marcello Rotta, MD, Barry E Storer, Thoralf Lange, MD, Michael Pulsipher, MD, Judith Shizuru, MD, PhD, Benedetto Bruno, MD, PhD, Peter A. McSweeney, MD, Edward Agura, MD, Thomas Chauncey, MD, PhD, Frederick R Appelbaum, MD, William Bensinger, MD, Brenda M Sandmaier, MD, Rainer F Storb, George E. Georges, MD, David G Maloney, MD, PhD

Blood (2009) 114 (22): 3391.

https://doi.org/10.1182/blood.V114.22.3391.3391

Published: 2009

Journal Articles

Intensive Supportive Care and Cytokines Promote Recovery of Hematopoiesis after Total Body Irradiation (TBI) without Hematopoietic Stem Cell Support.

George E. Georges, MD, Jyothi Pillai, MD, Vladimir Lesnikov, PhD, Marco Mielcarek, MD, Marina Lesnikova, PhD, Ya-Ju Laura Yang, BS, Anna Aragon, BS

Blood (2007) 110 (11): 1193.

https://doi.org/10.1182/blood.V110.11.1193.1193

Published: 2007

Journal Articles

Ex Vivo Expanded T Regulatory (Treg) Cells Block Conversion of Mixed Chimeras To Complete Donor Chimerism.

Marina Lesnikova, PhD, Alla Nikitine, MD, Nicola Mason, D.V.M, Richard A. Nash, MD, George E. Georges, MD

Blood (2006) 108 (11): 5168.

https://doi.org/10.1182/blood.V108.11.5168.5168

Published: 2006

Journal Articles

Dog Leukocyte Antigen (DLA)-Identical Sibling Cord Blood Transplantation (CBT) Following Myeloablative Total Body Irradiation (TBI).

Vladimir Lesnikov, MD, PhD, Szczepan Baran, V.D., Kraig Abrams, B.S., Alla Nikitine, MD, Billie Hwang, B.S., Eustacia Zellmer, B.S., Shelly Heimfeld, Ph.D., Marina Lesnikova, Ph.D., George E. Georges, MD

Blood (2006) 108 (11): 3192.

https://doi.org/10.1182/blood.V108.11.3192.3192

Published: 2006

Journal Articles

Nonmyeloablative Unrelated Donor (URD) Hematopoietic Cell Transplantation (HCT) for the Treatment of Patients (pts) with Poor-Risk, Relapsed or Refractory Multiple Myeloma.

George E. Georges, MD, Michael B. Maris, MD, David G. Maloney, MD, Brenda M. Sandmaier, MD, Mohamed L. Sorror, MD, Judith A. Shizuru, MD, Dietger W. Niederwieser, MD, Edward D. Agura, MD, Benedetto Bruno, MD, Peter A. McSweeney, MD, Michael A. Pulsipher, MD, Thomas R. Chauncey, MD, Barry E. Storer, PhD, Rainer F. Storb, MD

Blood (2005) 106 (11): 2893.

https://doi.org/10.1182/blood.V106.11.2893.2893

Published: 2005

Journal Articles

Peripheral CD4 + CD25 + Regulatory T Cells (T reg ) Block Alloreactive Host Anti-Donor T Cells in Canine Mixed Hematopoietic Chimeras.

Marina Lesnikova, PhD, Alla Nikitine, MD, Lina Pogosov, Richard A. Nash, MD, George E. Georges, MD

Blood (2005) 106 (11): 3101.

https://doi.org/10.1182/blood.V106.11.3101.3101

Published: 2005

Journal Articles

Ex Vivo Expansion of Canine CD4 + CD25 + Regulatory T Cells (T reg ) with Artificial Antigen Presenting Cells (aAPC).

Marina Lesnikova, PhD, Alla Nikitine, MD, Lina Pogosov, Nicola Mason, DVM, Richard A. Nash, MD, George E. Georges, MD

Blood (2005) 106 (11): 3102.

https://doi.org/10.1182/blood.V106.11.3102.3102

Published: 2005

NARROW

Conditioning Regimens and Outcomes after Allogeneic Hematopoietic Cell Transplant for Hyperinflammatory Inborn Errors of Immunity

Long-Term Tolerance to Kidney Allografts After Induced Rejection of Donor Hematopoietic Chimerism in a Preclinical Canine Model.

Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)

Sitagliptin Improves Engraftment and Platelet Recovery After Single Unit, Very Low Cell Dose Cord Blood Transplantation

Reduced Intensity Conditioning with Allogeneic Hematopoietic Cell Transplantation for the Treatment of High-Risk Acute Lymphoblastic Leukemia.

Nonmyeloablative Allogeneic HCT From Unrelated Donors for Multiple Myeloma (MM).

Intensive Supportive Care and Cytokines Promote Recovery of Hematopoiesis after Total Body Irradiation (TBI) without Hematopoietic Stem Cell Support.

Ex Vivo Expanded T Regulatory (Treg) Cells Block Conversion of Mixed Chimeras To Complete Donor Chimerism.

Dog Leukocyte Antigen (DLA)-Identical Sibling Cord Blood Transplantation (CBT) Following Myeloablative Total Body Irradiation (TBI).

Nonmyeloablative Unrelated Donor (URD) Hematopoietic Cell Transplantation (HCT) for the Treatment of Patients (pts) with Poor-Risk, Relapsed or Refractory Multiple Myeloma.

Peripheral CD4 + CD25 + Regulatory T Cells (T reg ) Block Alloreactive Host Anti-Donor T Cells in Canine Mixed Hematopoietic Chimeras.

Ex Vivo Expansion of Canine CD4 + CD25 + Regulatory T Cells (T reg ) with Artificial Antigen Presenting Cells (aAPC).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only